2601:HKEXChina Pacific Insurance (Group) Co., Ltd. Class H Analysis

China Pacific Insurance trades at HK$33.48, well below its DCF-derived fair value of HK$58.55, indicating a material discount of roughly 43%. The stock’s trailing P/E of 5.5 is far cheaper than the industry average of 16.35, reinforcing the undervaluation narrative. Revenue surged 54.6% year‑over‑year, driven by an 8.1% rise in life‑insurance premiums, while operating margins sit at a robust 60.2% and profit margin at 15.6%. Cash generation is strong with HK$782.6bn in cash and a modest payout ratio of 19.8%, supporting a 3.46% dividend yield that appears sustainable. Technicals show a neutral trend, a bearish MACD, and an RSI of 36, suggesting limited upside momentum in the short run but no immediate oversold condition. Volume is increasing, and the price is above the 20‑day SMA (35.61) yet below the 50‑day SMA (37.24), with support near HK$31.78 and resistance at HK$40.44. The beta of 0.22 (computed) and a 30‑day volatility of 33.6% point to low systematic risk but heightened price swings. Analyst consensus is a “strong buy” with a mean target of HK$43.36, implying a near‑term upside of about 30%. The combination of deep valuation discounts, solid earnings growth, and a resilient dividend makes the stock attractive for value‑oriented investors. However, the bearish MACD and neutral trend advise caution on timing, favoring accumulation rather than aggressive buying. Overall, the fundamentals outweigh the short‑term technical weakness, positioning CPIC as a compelling buy at current levels.